Cécile Gouttefangeas

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 932 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 641 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Response definition criteria for ELISPOT assays revisited

Zoe Moodie, Leah Price, Cécile Gouttefangeas et al. · Cancer Immunology Immunotherapy · 2010 · 229 citations · Full text

Life Sciences, Biostatistics, Immunology +16

Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

Saskia J. Santegoets, Eveline M. Dijkgraaf, Alessandra Battaglia et al. · Cancer Immunology Immunotherapy · 2015 · 203 citations · Full text

Life Sciences, Immunology, Oncology +17

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

Susanna Mandruzzato, Sven Brandau, Cedrik M. Britten et al. · Cancer Immunology Immunotherapy · 2016 · 199 citations · Full text

Medicine, Hematology, Oncology +15